Archive 2011-2015
A Monthly Review for Health Care Professionals
Pediatric Pharmacotherapy is a monthly newsletter providing a brief, referenced, peer-reviewed source of continuing medication information specifically related to children. The major focus is the initiation and monitoring of medications in the primary care setting.
Comments or questions? Contact Marcia L. Buck, Pharm.D., FCCP, FPPAG, at mlb3u@virginia.edu.
Newsletters download in PDF format.
1 Twenty-Year Cumulative Index
2 New Drugs for Children in the Food and Drug Administration Pipeline
3 9-Valent Human Papillomavirus Virus (HPV) Vaccine
4 Montelukast: A Review of Recent Studies in Pediatric Asthma and Allergic Rhinitis
5 Use of Aprepitant to Prevent Nausea and Vomiting in Children
6 Sumatriptan and Naproxen for Treatment of Migraine in Adolescents
7 Pediatric Vaccine Safety Monitoring
8 A New Once Daily Product for ADHD
9 Treatment Options for Head Lice in the Era of Increasing Pyrethroid Resistance
10 Tramadol: Weighing the Risks in Children
11 New Drug Approvals and Extended Indications for Infants, Children, and Adolescents
12 New Inhaled Formulations for the Treatment of Asthma in Children and Adolescents
1 Micafungin Use in the Treatment of Neonatal and Pediatric Fungal Infections
2 Everolimus Use in Children with Tuberous Sclerosis Complex
3 Use of Methylnaltrexone for Refractory Opioid-induced Constipation in Children
4 Treatment of Autonomic-Mediated Orthostatic Intolerance in Children and Adolescents
5 Use of Atropine in Infants and Children
6 New Drug and Drug Formulation Approvals for Children
7 Investigational Use of Meningococcal Serogroup B Vaccine
8 Treatment of Attention Deficit Hyperactivity Disorder: New Agents and Assessment Tools
11 Impact of Pediatric Labeling Changes on Cough and Cold Products
1 Eighteen-Year Cumulative Index
2 Antithrombin Administration During Pediatric Extracorporeal Membrane Oxygenation
3 Alternative Forms of Oral Drug Delivery for Pediatric Patients
4 Daptomycin Use in Infants and Children with Gram-Positive Infections
5 Remifentanil Use in Infants and Children
6 Update on Therapies for Pulmonary Arterial Hypertension in Children
7 Use of Topiramate in Preventing Pediatric Migraine
8 Options for Intranasal Procedural Sedation and Analgesia in Children
9 Use of Cisatracurium in the Pediatric Intensive Care Unit
11 Recent Literature on the Use of Clonidine in Children and Adolescents
12 Use of Lidocaine for Analgesia in Children and Adolescents
1 Use of Raltegravir in Pediatric HIV-1 Infection
2 Treatment of Hemolytic Uremic Syndrome with Eculizumab
3 The Placebo Response in Pediatric Clinical Trials
4 Ivacaftor for the Treatment of Patients with Cystic Fibrosis and the G551D-CFTR Mutation
5 Intranasal Ciclesonide for Treatment of Allergic Rhinitis in Children and Adolescents
6 New Options for Eradicating Resistant Head Lice
7 Fosamprenavir in Infants and Children with HIV-1 Infection
8 Meningococcal Groups C and Y and Haemophilus b Conjugate Vaccine
9 An Update on Oseltamivir Use in Infants and Children
10 FDA Drug Safety Update: Implications for Pediatric Health Care Providers
1 Sixteen-Year Cumulative Index
2 Pediatric Medications and the Development of REMS
3 Options for the Management of Attention Deficit/Hyperactivity (ADHD)
4 Intravenous Acetaminophen Use in Infants and Children
5 Loratadine and Desloratadine Use in Children
6 Trihexyphenidyl for the Management of Dystonia in Children
7 Lacosamide for the Treatment of Seizures in Children
8 Use of Intravenous Ketorolac for Postoperative Analgesia in Infants
9 Heparin and Enoxaparin in Infants and Children: Literature Update
10 An Update on Quadrivalent Meningococcal Conjugate Vaccines
11 Use of Bosentan in Pediatric Pulmonary Hypertension
12 Clobazam: A New Option for Children with Refractory Seizures